JP:2395 Stock Latest News
Company AnnouncementsSNBL Corrects Earnings Per Share Figure in Q1 FY2026 Disclosure2M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Lifts First-Half Earnings Forecast on Strong CRO Performance3M ago2395
Company AnnouncementsSNBL Sets New Management Structure and Highlights FY3/27 Q1 CRO Strategy3M ago2395
Company AnnouncementsSNBL Delivers Strong Q1 Earnings and Confirms Dividend Outlook3M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs5M ago2395
Company AnnouncementsSNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall5M ago2395Company AnnouncementsShin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus5M ago2395
Company AnnouncementsSNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push5M ago2395
Company AnnouncementsSNBL to Shift Meeting Leadership to Board Chair in Governance Revamp6M ago2395
Company AnnouncementsSNBL Revamps Top Management to Drive Long-Term Growth6M ago2395- Company AnnouncementsSNBL Releases Q3 FY2026 Results Briefing and Business Update9M ago2395
Company AnnouncementsSNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher9M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 202512M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits12M ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 20251y ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Announces Year-End Dividend1y ago2395
Company AnnouncementsShin Nippon Biomedical Laboratories Corrects Financial Results for FY 20251y ago2395